Circulating levels of Nε-(carboxymethyl)lysine are increased in systemic sclerosis

Rheumatology

Volumn 46, Issue 3, 2007, Pages 412-416

  Kaloudi, O ^a   Basta, G ^b   Perfetto, F ^a   Bartoli, F ^a   Del Rosso, A ^a   Miniati, I ^a   Conforti, M L ^a   Generini, S ^a   Guiducci, S ^a   Abbate, R ^a   Pignone, A ^a   Castellani, S ^a   Livi, R ^a   De Caterina, R ^b,c   Matucci Cerinic, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Advanced glycation endproducts; N (carboxymethyl)lysine (CML); System sclerosis

Indexed keywords

6 N CARBOXYMETHYLLYSINE; CALCIUM CHANNEL BLOCKING AGENT; GLYCERYL TRINITRATE; PROTON PUMP INHIBITOR; ADVANCED GLYCATION END PRODUCT; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DIAMETER; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; CAPILLAROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; ANGIOSCOPY; BLOOD; INTIMA; METHODOLOGY; MICROCIRCULATION; MIDDLE AGED; PATHOLOGY; TUNICA MEDIA;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MALE; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TUNICA INTIMA; TUNICA MEDIA;

EID: 33847398727     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel076     Document Type: Article

References (32)

1. Clements PJ, Furst DE (ed.). Systemic sclerosis, 3rd edn. Baltimore, MD: Williams & Wilkins, 2003.
2. Guiducci S, Matucci Cerinic M. Raynaud's phenomenon. In: Furst D, Clements P, ed. Systemic sclerosis. Baltimore, MD: Williams & Wilkins, 2003:221.
3. Herrick AL, Matucci Cerinic M. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 2001;19:4-8.
4. Simonini G, Matucci Cerinic M, Generini S et al. Oxidative stress in systemic sclerosis. Mol Cell Biochem 1999;196:85-91.
5. Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum 1995;38:1060-7.
6. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998;37:586-600.
7. Basta G, Lazzerini G, Massaro M et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: A mechanism for amplification of inflammatory responses Circulation 2002;105:816-22.
8. Vlassara H, Palace MR. Diabetes and advanced glycation end-products. J Intern Med 2002;251:87-101.
9. Stitt AW, He C, Friedman S et al. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: Relationship to tissue AGEs. Mol Med 1997;3:617-27.
10. Matucci-Cerinic M, Fiori G, Grenbaum E, Shoenfeld Y. Macrovascular disease in systemic sclerosis. In: Furst D, Clements P, ed. Systemic sclerosis. Baltimore, MD: Williams & Wilkins, 2003:241.
11. Fatini C, Guiducci S, Abbate R, Matucci-Cerinic M. Vascular injury in systemic sclerosis: Angiotensin-converting enzyme insertion/deletion polymorphism. Curr Rheumatol Rep 2004;6:149-55.
12. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells the pathogenic and diagnostic implications. Arthritis Rheum 2001; 44:1484-94.
13. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
14. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
15. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMGCoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005;6:3-8.
16. Sinha AK, Eigenbrodt M, Mehta JL. Does carotid intima media thickness indicate coronary atherosclerosis? Curr Opin Cardiol 2002;17:526-30.
17. Norman PE, Eikelboom JW, Hankey GH. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications Med J Aust 2004;181:150-4.
18. Walker WF, Spencer VA, MacCollum PT. Systolic pressure measurement in the ischemic lower limb. Hospital Update 1986;3:43-58.
19. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991;87:118-28.
20. Bernstein EF, Fronnek A. Current status of non invasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 1982; 62:473-87.
21. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995;34: 10872-8.
22. Purcell JM, Quimby DJ, Cavanaugh A. New method for determination of free amino groups in intact pure proteins: Relationship to available lysine. J Assoc Off Anal Chem 1976;59:1251-4.
23. Ikeda K, Higashi T, Sano H et al. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996;35:8075-83.
24. Mitsuhashi T, Vlassara H, Founds HW, Li YM. Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. J Immunol Methods 1997;207:79-88.
25. Makita Z, Vlassara H, Rayfield E et al. Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 1992;258:651-3.
26. Chen JR, Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology 1999;38:1275-8.
27. Nerlich AG, Schleicher ED. N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress. Atherosclerosis 1999;144:41-7.
28. Schimdt AM, Jan SD, Woautier GL, Stern D. Activation of receptor of advanced glycation and products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-97.
29. O'Leary DH, Polak JF. Intima-media thickness: A tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002;90: 18L-21L.
30. Touboul MG, Hennerici S, Meairs H et al. Intima-media thickness consensus. Cerebrovasc Dis 2004;18:346-9.
31. Cerami C, Founds H, Nicholl I et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 1997; 94:13915-20.
32. Matthew D, Oldfield LA, Bach JM et al. AGEs cause epithelial-myofibroblast transdifferation via the RAGE. J Clin Invest 2001; 108:1853-63.